# Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL)

> **NCT03454646** · PHASE4 · NOT_YET_RECRUITING · sponsor: **University Hospital, Bordeaux** · enrollment: 1205 (estimated)

## Conditions studied

- Alzheimer Disease
- Cholinesterase Inhibitors

## Interventions

- **DRUG:** cholinesterase inhibitors (CI) (donepezil, galantamine or rivastigmine)

## Key facts

- **NCT ID:** NCT03454646
- **Lead sponsor:** University Hospital, Bordeaux
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2027-04-27
- **Final completion:** 2027-09-15
- **Target enrollment:** 1205 (ESTIMATED)
- **Last updated:** 2023-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03454646

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03454646, "Comparison of Therapeutic Strategies With Cholinesterase Inhibitors (SOS TRIAL)". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03454646. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*